Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity

Sernia, Conrad and Brown, Lindsay (2011) Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity. American Journal of Hypertension, 24 (7). p. 739. ISSN 0895-7061

Abstract

In summary, angiotensin receptor antagonists with pleiotropic properties, such as telmisartan, have a great deal to recommend them in the treatment of the metabolic syndrome: they are antihypertensive, anti-inflammatory, may lower blood glucose concentrations, and normalize lipid homeostasis.


Statistics for USQ ePrint 19930
Statistics for this ePrint Item
Item Type: Article (Commonwealth Reporting Category C)
Refereed: Yes
Item Status: Live Archive
Additional Information: Permanent restricted access to published version due to publisher copyright policy. Note this is a C4 publication.
Depositing User: Professor Lindsay Brown
Faculty / Department / School: Historic - Faculty of Sciences - Department of Biological and Physical Sciences
Date Deposited: 08 Feb 2012 06:33
Last Modified: 08 Oct 2014 22:48
Uncontrolled Keywords: metabolic syndrome; angiotensin receptor antagonists
Fields of Research (FOR2008): 11 Medical and Health Sciences > 1103 Clinical Sciences > 110306 Endocrinology
11 Medical and Health Sciences > 1101 Medical Biochemistry and Metabolomics > 110107 Metabolic Medicine
06 Biological Sciences > 0606 Physiology > 060699 Physiology not elsewhere classified
Socio-Economic Objective (SEO2008): C Society > 92 Health > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920104 Diabetes
Identification Number or DOI: doi: 10.1038/ajh.2011.61
URI: http://eprints.usq.edu.au/id/eprint/19930

Actions (login required)

View Item Archive Repository Staff Only